COSCIENS Biopharma Valuation
| CSCI Stock | 2.10 0.05 2.44% |
Based on Macroaxis valuation methodology, the firm appears to be fairly valued. COSCIENS Biopharma shows a prevailing Real Value of USD2.04 per share. The current price of the firm is USD2.1. Our model approximates the value of COSCIENS Biopharma from analyzing the firm fundamentals such as profit margin of (2.00) %, and Return On Equity of -1.13 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting COSCIENS Biopharma's valuation include:
Price Book 1.1684 | Enterprise Value | Enterprise Value Ebitda 3.3303 | Price Sales 0.9152 | Enterprise Value Revenue 0.1389 |
Fairly Valued
Today
Please note that COSCIENS Biopharma's price fluctuation is abnormally volatile at this time. Calculation of the real value of COSCIENS Biopharma is based on 3 months time horizon. Increasing COSCIENS Biopharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since COSCIENS Biopharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of COSCIENS Stock. However, COSCIENS Biopharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.1 | Real 2.04 | Hype 2.09 | Naive 1.88 |
The intrinsic value of COSCIENS Biopharma's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence COSCIENS Biopharma's stock price.
Estimating the potential upside or downside of COSCIENS Biopharma helps investors to forecast how COSCIENS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of COSCIENS Biopharma more accurately as focusing exclusively on COSCIENS Biopharma's fundamentals will not take into account other important factors: When choosing an evaluation method for COSCIENS Biopharma, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
COSCIENS Biopharma Cash |
|
About COSCIENS Biopharma Valuation
An absolute valuation paradigm, as applied to COSCIENS Stock, attempts to find the value of COSCIENS Biopharma based on its fundamental and basic technical indicators. By analyzing COSCIENS Biopharma's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of COSCIENS Biopharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of COSCIENS Biopharma. We calculate exposure to COSCIENS Biopharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of COSCIENS Biopharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 7.8 M | 8.2 M | |
| Pretax Profit Margin | (1.27) | (1.21) | |
| Operating Profit Margin | (1.72) | (1.63) | |
| Net Loss | (1.00) | (1.05) | |
| Gross Profit Margin | 0.44 | 0.37 |
COSCIENS Biopharma Current Valuation Indicators
Valuation refers to the process of determining the present value of COSCIENS Biopharma and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value COSCIENS we look at many different elements of the entity such as COSCIENS's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as COSCIENS Biopharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use COSCIENS Biopharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes COSCIENS Biopharma's worth.Complementary Tools for COSCIENS Stock analysis
When running COSCIENS Biopharma's price analysis, check to measure COSCIENS Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy COSCIENS Biopharma is operating at the current time. Most of COSCIENS Biopharma's value examination focuses on studying past and present price action to predict the probability of COSCIENS Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move COSCIENS Biopharma's price. Additionally, you may evaluate how the addition of COSCIENS Biopharma to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |